Prevention and treatment of postmenopausal osteoporosis

Authors

  • Sunna Kwun MD,

    Endocrine Fellow
    1. Division of Endocrinology, Alpert Medical School of Brown University, Hallett Center for Diabetes and Endocrinology, East Providence, RI, USA
    Search for more papers by this author
  • Marc J Laufgraben MD MBA FACE FACP,

    Division Head
    1. Division of Endocrinology, Diabetes, and Metabolism, Cooper Medical School of Rowan University, Cooper University Hospital, Camden, NJ, USA
    Search for more papers by this author
  • Geetha Gopalakrishnan MD

    Corresponding author
    1. Alpert Medical School of Brown University Medicine, RI, USA
    • Division of Endocrinology, Alpert Medical School of Brown University, Hallett Center for Diabetes and Endocrinology, East Providence, RI, USA
    Search for more papers by this author

Correspondence: Geetha Gopalakrishnan. Email: ggopala@lifespan.org

Abstract

Key content

  • Osteoporotic fractures are associated with increased morbidity and mortality.
  • Clinical history and bone densitometry can identify individuals at risk for osteoporotic fractures.
  • Treatment is available to prevent and treat osteoporosis.

Learning objectives

  • Identify populations at risk for osteoporotic fractures.
  • Make the diagnosis of osteoporosis.
  • Decide appropriate treatment for the prevention or treatment of osteoporosis.

Ethical issues

  • Maximising health benefit while minimising financial implications.

Ancillary